The human genome has generated hundreds of potential new drug targets. Validation of these targets with respect to their relevance to human disease has never been more important and is a vital step in ...

The "Rising Stars in Drug Metabolism and Transport 2025/2026" highlights the groundbreaking work of early-career researchers ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

For both research and therapeutic purposes, antibodies can be used to affect cellular processes in vivo and referred to as functional/in vivo grade antibodies. There are a wide range of applications ...

The convergence of genomics, systems biology, and artificial intelligence is transforming the landscape of drug discovery. Modern genomic technologies now ...

Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

If approved, TSRA-196 could become the first curative therapy to reach patients with AATD.

Aging is defined as the deterioration of function over time, and it is one of the main risk factors for numerous chronic ...

Engineers at Stanford University and at Georgia Institute of Technology have created a small, autonomous device with a stretchable/flexible sensor that can be adhered to the skin of cancer-bearing ...

Vivan Therapeutics and the MRC Laboratory of Medical Sciences Announces a Pioneering Partnership to Explore How Specific Cancer Mutations, Diabetes & Diet Influence Drug Response London, UK [November ...